Literature DB >> 16799039

Macrophages are vital in spontaneous intraocular tumor eradication.

Zita F H M Boonman1, Lucas R H M Schurmans, Nico van Rooijen, Cornelis J M Melief, René E M Toes, Martine J Jager.   

Abstract

PURPOSE: Injection of tumor cells transformed by the early region 1 of human adenovirus type 5 (Ad5E1) in the anterior chamber (AC) of C57BL/6 mice leads to intraocular tumor formation. This tumor disappears spontaneously 3 to 4 weeks after tumor inoculation without damaging the neighboring ocular tissues. Previous studies have shown that CD4+ T cells, IFNgamma, and TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) play a role in the spontaneous eradication of this particular intraocular tumor. This study was conducted to determine whether macrophages are involved in the natural elimination of this intraocular tumor.
METHODS: Ad5E1-expressing tumor cells were inoculated into the AC of syngeneic C57BL/6 mice. Macrophage depletion was obtained by subconjunctival (scj), subcutaneous (sc), or intravenous (iv) injection of clodronate liposomes 2, 8, and 14 days after tumor inoculation. Control C57BL/6 mice received PBS liposomes at similar time points after tumor injection or were left untreated. The presence of macrophages in the AC tumor was determined with the macrophage marker F4/80.
RESULTS: Progressive tumor growth was observed in mice that were subconjunctivally depleted of macrophages, whereas spontaneous tumor eradication occurred in all other groups. F4/80 staining was negative in the AC tumors of mice treated scj with clodronate liposomes in contrast to the positive F4/80 staining in the tumors of the other groups. Ad5E1 tumor antigen still reached the tumor-draining lymph nodes (DLNs) of mice locally depleted for macrophages.
CONCLUSIONS: Local macrophages in the eye are involved in the process of spontaneous AC tumor eradication in mice. However, it is not conclusive from these data exactly how tumor-specific CD4+ T cells and macrophages interact with each other to eliminate the Ad5E1-AC tumor without any collateral eye damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16799039     DOI: 10.1167/iovs.05-1427

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

1.  Macrophages feel their age in macular degeneration.

Authors:  Martine J Jager; Caroline C W Klaver
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

2.  CTL induction of tumoricidal nitric oxide production by intratumoral macrophages is critical for tumor elimination.

Authors:  Rodolfo D Vicetti Miguel; Thomas L Cherpes; Leah J Watson; Kyle C McKenna
Journal:  J Immunol       Date:  2010-11-01       Impact factor: 5.422

Review 3.  Immune escape mechanisms of intraocular tumors.

Authors:  Jerry Y Niederkorn
Journal:  Prog Retin Eye Res       Date:  2009-06-27       Impact factor: 21.198

Review 4.  Influence of immune privilege on ocular tumor development.

Authors:  Kyle C McKenna; Peter W Chen
Journal:  Ocul Immunol Inflamm       Date:  2010-04       Impact factor: 3.070

5.  Abrogating TNF-α expression prevents bystander destruction of normal tissues during iNOS-mediated elimination of intraocular tumors.

Authors:  Terry G Coursey; Peter W Chen; Jerry Y Niederkorn
Journal:  Cancer Res       Date:  2011-02-09       Impact factor: 12.701

6.  IFN-γ-independent intraocular tumor rejection is mediated by a macrophage-dependent process that leaves the eye intact.

Authors:  Terry G Coursey; Peter W Chen; Jerry Y Niederkorn
Journal:  J Leukoc Biol       Date:  2012-06-12       Impact factor: 4.962

7.  Impact of tumor-associated macrophages in LH(BETA)T(AG) mice on retinal tumor progression: relation to macrophage subtype.

Authors:  Yolanda Piña; Hinda Boutrid; Timothy G Murray; Martine J Jager; Colleen M Cebulla; Amy Schefler; Long V Ly; Armando Alegret; Magda Celdran; William Feuer; Maria-Elena Jockovich
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-06       Impact factor: 4.799

8.  CD4+ T-cell-dependent tumour rejection in an immune-privileged environment requires macrophages.

Authors:  Dru S Dace; Peter W Chen; Jerry Y Niederkorn
Journal:  Immunology       Date:  2007-10-17       Impact factor: 7.397

9.  Splenectomy promotes indirect elimination of intraocular tumors by CD8+ T cells that is associated with IFNγ- and Fas/FasL-dependent activation of intratumoral macrophages.

Authors:  Maxine R Miller; Jonathan B Mandell; Kelly M Beatty; Stephen A K Harvey; Michael J Rizzo; Dana M Previte; Stephen H Thorne; Kyle C McKenna
Journal:  Cancer Immunol Res       Date:  2014-09-23       Impact factor: 11.151

10.  Influence of CD8+ T regulatory cells on intraocular tumor development.

Authors:  Kyle C McKenna; Dana M Previte
Journal:  Front Immunol       Date:  2012-09-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.